Reuters logo
REFILE-BRIEF-Photocure ASA to terminate the global licensing agreement for Lumacan
August 18, 2014 / 6:31 AM / 3 years ago

REFILE-BRIEF-Photocure ASA to terminate the global licensing agreement for Lumacan

(Refiles to add a code for Salix Pharmaceuticals ) Aug 18 (Reuters) - Photocure ASA : * Says agreed to terminate the global licensing agreement for Lumacan with Salix Pharmaceuticals * Says Will receive a payment of US$ 5M from Salix and will regain the global rights and all intellectual property to Lumacan. * Source text for Eikon * Further company coverage

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below